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of SNM in patients with hypocontractility was 67 % and in 
acontractile patients 35 %. According to ambulatory-UDS 
diagnosis, success rates were 32 and 17 %, respectively.
Conclusions This study shows that conventional-UDS 
overestimates the amount of patients diagnosed with hypo-
contractile or acontractile bladder. Patients with reduced 
contractility on ambulatory-UDS have a lower chance of 
SNM success. Hence, ambulatory-UDS allows us to select 
patients with a real acontractile bladder and predict SNM 
failure. In patients with storage dysfunction, additional 
ambulatory-UDS does not seem to contribute in predicting 
SNM outcome.
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Abbreviations
Ambulatory-UDS  Ambulatory urodynamic study
Conventional-UDS  Conventional urodynamic study
DO  Detrusor overactivity
DU  Detrusor underactivity
NOR  Non-obstructive urinary retention
OAB  Overactive bladder
SNM  Sacral neuromodulation
Introduction
Since the 1990s, sacral neuromodulation (SNM) is recom-
mended as a secondary treatment option if conservative 
treatments either fail or lead to adverse events in patients 
with overactive bladder syndrome (OAB) or non-obstruc-
tive urinary retention (NOR). OAB syndrome is defined 
Abstract 
Purpose The aim of this study is to explore whether uro-
dynamics, with the addition of ambulatory urodynamic 
study (ambulatory-UDS), will be able to better predict and 
assess sacral neuromodulation (SNM) treatment outcome. 
Selection of patients is a critical element in achieving opti-
mal outcome in SNM. Quantitative and qualitative results 
of urodynamic tests are used to justify surgical therapy and 
to evaluate treatment for lower urinary tract dysfunction. 
Therefore, these tests should be representative and subse-
quently offer a correct prognosis.
Methods Between December 2002 until May 2013 
selected patients with lower urinary tract symptoms (stor-
age and/or voiding dysfunction) were included in an ambu-
latory urodynamic measurement database. From this data-
base, the total subgroup of patients that underwent a sacral 
neuromodulation test evaluation was selected.
Results A total of 98 patients were included. Success rate 
of SNM in patients with storage dysfunction was around 
70 %, according to either conventional-UDS or ambulatory-
UDS diagnosis. Based on conventional-UDS, success rate 
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by the International Continence Society (ICS) as urgency, 
frequency and/or nocturia with or without urgency incon-
tinence [1]. NOR has a multifactorial aetiology and can 
be caused by detrusor underactivity (DU), detrusor-blad-
der neck dyssynergia, detrusor-external sphincter dys-
synergia, dysfunctional voiding and non-relaxing ure-
thral sphincter obstruction. Treatment success of these 
storage and voiding dysfunctions is evaluated in terms 
of improvement in micturition diaries, subjective patient 
evaluation, quality of life scores and symptom score 
questionnaires.
Conventional urodynamic studies (conventional-UDS) 
use retrograde bladder filling via a catheter to monitor 
storage and voiding in a patient. Ambulatory urodynamic 
studies (ambulatory-UDS) aim to evaluate storage and 
voiding during natural filling of the bladder [2]. Since 
the development of ambulatory-UDS in the 1990s [2, 3], 
many studies have been performed to assess the utility 
of ambulatory-UDS in clinical practice. Ambulatory uro-
dynamic studies were standardised in 2000 [4], but have 
yet to be clinically validated. It can be expected that the 
ambulatory-UDS technique is more sensitive in record-
ing pressure/flow changes than conventional urodynamic 
measurements, which are currently the gold standard in 
urodynamics. However, ambulatory-UDS may also be 
more sensitive to artifacts and could be more prone to 
record or elicit non-physiological detrusor behaviour [5]. 
Others mention that the rapid filling in conventional-UDS 
could elicit artifacts and/or mask (other) artifacts that do 
manifest themselves during ambulatory-UDS [6]. These 
and other factors make validation a complex task. None-
theless, it remains a necessary step in the clinical appli-
cation of ambulatory-UDS. To correctly validate ambula-
tory-UDS, urodynamic results of conventional-UDS and 
ambulatory-UDS should be compared with each other 
on a large scale and both should be related to treatment 
outcome in different treatment modalities. One of these 
treatment modalities is SNM. In most studies with SNM 
treatment, success is defined as a reduction in one or more 
micturition symptoms of ≥50 %, compared to baseline, 
determined by comparing voiding diaries. However, also 
changes in urodynamic parameters during SNM have 
been reported by several research groups. In patients with 
NOR treated with SNM, a significant correlation was 
found between improvement in symptoms and changed 
conventional-UDS recording [7–9]. Several researchers 
found a similar significant correlation in OAB patients 
treated with SNM [10–12].
In this article, outcomes of conventional-UDS and 
ambulatory-UDS in patients evaluated with SNM are 
reviewed with a focus on the treatment outcome. The aim 
of this study is to explore to what extent a urodynamic 
diagnosis, with the addition of ambulatory-UDS, will be 
able to predict sacral neuromodulation treatment outcome 
even before SNM test evaluation is performed.
Patients and methods
Selected patients underwent, besides a conventional-UDS, 
an additional ambulatory-UDS before starting (if any) 
treatment. Reasons for ambulatory-UDS were as follows: 
(1) low-quality conventional-UDS (2) assumed OAB syn-
drome without detrusor overactivity on conventional-UDS 
(3) incontinence with unclear primary origin (4) suspected 
bladder acontractility and (5) enuresis nocturna. All patients 
in this study underwent conventional and ambulatory uro-
dynamic monitoring before treatment evaluation with sacral 
neuromodulation between December 2002 and April 2013. 
Clinical informed consent was obtained from all patients for 
the additional ambulatory-UDS. All urodynamic measure-
ments were performed with the use of Medical Measure-
ments Systems (MMS B.V., Enschede, The Netherlands) 
equipment and according to the standardisation report of 
the ICS [4, 13]. Any phasic contraction during the filling 
phase with rise and fall in detrusor pressure is diagnostic 
of detrusor overactivity (DO). The ICS definition does not 
specify a minimum change in detrusor pressure, although 
waves of an amplitude <5 cm H2O are difficult to detect. 
Bladder acontractility was defined as a filling and voiding 
phase without detrusor pressure rise. Hypocontractility was 
identified as a low detrusor pressure (<10 cm H2O) during 
the voiding phase, relative to the degree of obstruction, not 
resulting in (efficient) micturition. In the case of a conven-
tional-UDS, the hypocontractility definition is elaborated 
with a peak flow rate (Qmax) of <10 mL/s, voided volume 
should be >100 mL and residual urine volume >150 mL 
[14]. For ambulatory-UDS standardised limits have not 
yet been established. The quality of all ambulatory-UDS 
recordings was probed, and the full results were interpreted 
by a staff member specialised in urodynamics and a resident 
experienced in judging urodynamic measurements. SNM 
treatment success is defined as a reduction in one or more 
micturition symptoms of ≥50 %, compared to baseline, 
determined by comparing voiding diaries.
Statistical analysis
Descriptive and comparative statistics were calculated with 
the use of SPSS, IBM corporation, version 20. Median and 
25–75 percentile interquartile range (IQR) were stated. 
Nominal association variables and measurement of agree-
ment between conventional-UDS and ambulatory-UDS 
were calculated. Logistic regression analysis was per-
formed to compare success rate by conventional and ambu-
latory urodynamic diagnoses.
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Results
A total of 98 patients underwent conventional-UDS and 
ambulatory-UDS before the neuromodulation test. The 
median age of included patients was 54 years (IQR 45–62), 
and the group consisted of 67 women and 31 men. Reasons 
for conducting a conventional-UDS were OAB (n = 25: 
wet, n = 3: dry), mixed urinary incontinence (n = 11) and 
voiding problems (n = 59). In 44 patients, the ambulatory-
UDS was conducted after an inconclusive or unrepresenta-
tive conventional-UDS, in 40 patients because of alleged 
acontractility or hypocontractility, and in 14 patients 
because of OAB symptoms without DO on conventional-
UDS. The median (IQR) duration of an ambulatory-UDS 
was 5.5 h (4.1–6.0), with a median drinking volume dur-
ing the assessment of 1,400 mL (1,025–1,860) and median 
urine production of 660 mL (265–1,050). In 54 (55 %) 
patients, the evaluation led to permanent treatment with 
sacral neuromodulation. Twelve patients experienced faecal 
incontinence in addition to urgency urinary incontinence. 
In 67 % of these patients, faecal incontinence symptoms 
decreased by ≥50 % during SNM.
Conventional-UDS and ambulatory-UDS outcomes 
compared
Overall there is a high association between conventional-
UDS and ambulatory-UDS outcomes (Cramer’s V = 0.336 
(p < 0.001), Pearson’s contingency coefficient: C = 0.558 
(p < 0.001)) see Table 1, subset A. Success rates based 
on conventional-UDS are not significantly (V = 0.272 
(p = 0.124), C = 0.262 (p = 0.124)) different from the suc-
cess of patients with normal conventional-UDS recordings, 
no matter what the specific diagnosis, as can be seen in 
Fig. 1. The association between outcomes of conventional-
UDS and successful SNM treatment is also not significant 
when stratified for patients based on history of storage or 
voiding dysfunction. This is in contrast to the relation-
ship between outcomes of ambulatory-UDS and success-
ful SNM treatment, as the there is a moderate association 
[V = 0.435 (p = 0.001), C = 0.399 (p = 0.001)], between 
them.
Storage dysfunction
SNM treatment success rates were around 70 % in patients 
with a diagnosis of OAB after history taking and perfor-
mance of urodynamics (Fig. 1). The total group was also 
stratified purely on history taking between (mainly) storage 
or voiding dysfunction. Of the 39 patients with a history 
of storage dysfunction, only 11 showed signs of OAB on 
conventional-UDS. On the other hand, 26 showed indica-
tions of OAB on ambulatory-UDS. Of these 39, only seven 
patients (18 %) showed DO on conventional urodynam-
ics. On ambulatory-UDS of the same patients, 32 (82 %) 
showed contractions during the filling phase. These 32 
patients included the seven patients with DO on conven-
tional-UDS. If storage dysfunction was confirmed on both 
urodynamic tests, success rate was almost 40 % higher 
(Table 1, subset B) than when only seen on one of both 
tests (success rates were on average 79 %). If storage dys-
function was only seen on one of the two, success rate on 
average was 57 %, regardless of the urodynamic test. The 
presence or absence of DO or ‘detrusor contractions during 
the filling phase’ in addition to the storage symptoms did 
not change this similarity in success rate for both conven-
tional-UDS and ambulatory-UDS. This is in concordance 
with the finding that when SNM is successful in patients 
with a history of storage dysfunction, there is a significant 
association between the conventional-UDS-based and the 
ambulatory-UDS-based diagnoses (C = 0.767, p < 0.001).
Voiding dysfunction
Of the group of patients with a history of voiding dys-
function, 53 % (31 of 59) had a successful SNM evalua-
tion period (Table 1, subset C). Of these 59 patients with 
a history of bladder emptying problems, 23 (39 %) were 
acontractile on conventional-UDS. On ambulatory-UDS, 
only 6 (10 %) of the 59 appeared to be acontractile. Hence, 
in 78 % of patients (18/23), the diagnosis of acontractility 
on conventional-UDS was not confirmed on ambulatory-
UDS. All five patients with acontractility on both con-
ventional-UDS and ambulatory-UDS failed the SNM test 
period. Eight (35 %) of these 23 patients showed hypocon-
tractility on ambulatory-UDS, and 63 % of these patients 
underwent successful SNM test period. Additionally, nine 
patients showed hypocontractility on conventional-UDS, of 
which four were also hypocontractile on ambulatory-UDS. 
If hypocontractility was confirmed by ambulatory-UDS, 
failure rate was 40 % higher than when diagnosis was only 
based on conventional-UDS. Finally, three patients with 
a history of storage dysfunction appeared to be acontrac-
tile on conventional-UDS, and none of these patients were 
acontractile on ambulatory-UDS. These patients also had a 
successful neuromodulation test.
Long-term response
Of all 98 patients evaluated, 54 (55 %) underwent perma-
nent implantation as a result of significant reduction in 
symptoms during the test stimulation. After 1 year, 98 % 
still were successfully treated (without a decline of the ini-
tial improvement), after 2 years this percentage dropped 
to 94 %, as is shown in Fig. 1. Several patients (n = 19) 
are treated with SNM for a period longer than 5 years, and 
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in this group most patients (89 %) still have a favourable 
effect of the treatment. In case patients show an effect dur-
ing initial SNM evaluation, there is no significant differ-
ence (p > 0.05) between the different SNM indications with 
regard to long-term effect.
Discussion
In the past, it has been attempted to identify which patients 
are more likely to benefit from treatment with SNM. It 
appears to be difficult to define reliable predictive factors 
[15, 16]. It is assumed that patients with a real acontrac-
tile bladder have a lower SNM treatment success rate [8]. 
However, how to determine this real acontractile blad-
der remained unclear [17]. Some also assumed that OAB 
patients with DO on urodynamics could have a higher 
potential treatment success, compared to the OAB patients 
without DO [15].
This study is relating urodynamic recordings, taking 
symptom presentation into account, to treatment outcome 
in SNM and could be a first step towards validation of the 
ambulatory-UDS. It provides clues that performing ambu-
latory urodynamics in selected patients will lead to a better 
patient selection and thus more successful SNM outcomes. 
In this study treatment, success rate amongst patients with 
storage dysfunction (around 70 %) was higher than in 
the patients with voiding dysfunction (around 50 %). The 
Table 1  Urodynamic confirmation between conventional and ambulatory urodynamic studies
Cramer’s V = 0.336 (p < 0.001). Pearson’s contingency coefficient: C = 0.558 (p < 0.001)
When SNM is successful in patients with a history of storage dysfunction, there is a significant association between the conventional-UDS-based 
and the ambulatory-UDS-based diagnoses (C = 0.767, p < 0.001). If SNM is not successful, no relation is seen
a-UDS ambulatory urodynamic study, c-UDS conventional urodynamic study, OAB overactive bladder, DO detrusor overactivity
a OAB consists out of OAB-dry and OAB-wet
b The seven patients with OAB with DO are amongst the 11 OAB patients
c Of the 18 patients of hypocontractile on ambulatory-UDS, ten were only hypocontractile and the eight others had also filling phase contrac-
tions. In patients with a history of voiding dysfunction, no significant association is seen, independent of successful SNM
Conventional-UDS outcome Ambulatory-UDS outcome Total
Normal OAB Dysfunctional Hypocontractile Acontractile
Subset A: 5 × 5 contingency table for conventional-UDS and ambulatory-UDS
 Normal 2 19 1 1 1 24
 OAB 1 8 3 2 0 14
 Dysfunctional 0 6 6 7 0 19
 Hypocontractile 3 3 5 4 0 15
 Acontractile 2 3 8 8 5 26
 Total 8 39 23 22 6 98
Conventional-UDS  
diagnosis
Patients (n), SNM  
successful (%)
Confirmed on a-UDS (n),  
SNM successful (%)
SNM successful (n) in  
unconfirmed group (%)
Diagnosis solely on a-UDS 
(n) and success (%)
Subset B: patients clustered by history of storage symptoms
 OABa 11 (64) 6 (83) 2 (40) 26 (62)
 OAB with DO 7 (57) 4 (75) 1 (33) 21 (62)
 Normal 18 (56)
 Voiding dysfunction 10 (60)
 Total 39 (59)b
Conventional-UDS  
diagnosis
Patients (n), SNM  
failure (%)
Confirmed on a-UDS (n),  
SNM failure (%)
SNM failure in  
unconfirmed group (%)
Diagnosis solely on a-UDS 
(n) and failure (%)
Subset C: patients clustered by history of voiding symptoms
 Acontractile 23 (65) 5 (100) 10 (66) 1 (100)
 Hypocontractile 9 (33) 4 (75) 0 (0) 18 (78)c
 Dysfunctional voiding 18 (39) 8 (37) 4 (40) 10 (50)
 Normal 6 (50)
 Storage dysfunction 3 (0)
 Total 59 (47)
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lowest success rate was seen in the patients with hypoc-
ontractility or acontractility on ambulatory-UDS (respec-
tively, 32 and 17 %). In 78 %, the diagnosis of acon-
tractility on conventional-UDS was not confirmed with 
ambulatory-UDS.
Although ambulatory-UDS is not validated yet, the 
recording of a detrusor contraction can easily be detected. 
An acontractile bladder confirmed on ambulatory-UDS is 
therefore definitely more reliable to be a real acontractile 
bladder.
Filling phase contractions were more abundant on ambu-
latory-UDS recordings than on conventional-UDS in this 
study. Both on conventional-UDS and on ambulatory-UDS, 
the presence of OAB with DO or filling phase contrac-
tions did not lead to a difference in outcome, compared to 
patients with OAB without these contractions. In another 
study, OAB patients were treated with Onabotulinumtox-
inA bladder injections, and treatment outcome does not 
appear to be related to the pretreatment urodynamic finding 
of DO neither [18].
In general not only in symptomatic patients [6], but also 
in asymptomatic individuals, an increase in the number of 
detrusor contractions during the storage phase on ambu-
latory-UDS has been found [2, 19, 20]. It has been noted 
that about 50 % of patients are continuously aware of the 
catheter and have increased urge sensation, but they volun-
tarily suppress their reaction [2]. Detrusor overactivity has 
also been found on ambulatory-UDS in patients with only 
stress urinary incontinence symptoms [21, 22]. The signif-
icance of detrusor contractions without subsequent leak-
age in asymptomatic patients is unknown. The increased 
number of contractions can be elicited by catheter irrita-
tion or due to artifacts. It cannot be excluded nor proven 
that the bladder catheter is a non-physiological trigger 
and may explain the high incidence of detrusor over-
activity [23]. The meaning of this higher false-negative 
rate in diagnosing DO on conventional-UDS compared 
to ambulatory-UDS has yet to be elucidated [24]. DO 
seen on ambulatory-UDS may have other diagnostic and 
therapeutic consequences than DO seen on conventional-
UDS. Therefore, the meaning of DO on ambulatory-UDS 
needs further explanation. However, these findings will not 
change the conclusions based on our results, as was shown 
that the detection of DO does not predict a different SNM 
treatment outcome.
The patients included in this study are a clinically pre-
selected group with more complex pathology, compared to 
other patients that did not undergo additional ambulatory-
UDS. This can also explain the lower average success rate 
of SNM evaluation (54 %), as this is around 70 % in the 
total treatment group in our tertiary referral population. 
This patient selection raises a risk of bias, as ambulatory 
urodynamics is performed on specific indication, rather 
than randomly.
Fig. 1  Storage and voiding related urodynamic diagnoses are not 
clustered by (extensive) symptom history. Success rate at long term 
(2 years) is additionally depicted. Normal: patients with subjective 
complaints, only represented in voiding diaries but not on conven-
tional-UDS or ambulatory-UDS. Dysfunctional: patients with dys-
functional voiding or functional obstruction. Among the patients with 
hypocontractility there are also patients with filling phase contrac-
tions combined with impaired contractility during micturition phase. 
* Chance of success is significantly (p < 0.05) lower for the differ-
ent ambulatory-UDS outcomes compared to a normal outcome. For 
conventional-UDS outcomes this is not the case (logistic regression 
analysis). UDS urodynamic study, OAB overactive bladder syndrome, 
SNM sacral neuromodulation
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Another point of discussion is the representativeness of 
the diagnosis in repeated urodynamic studies. Regardless 
of the urodynamic study being ambulatory or conventional, 
the fact of having multiple urodynamic studies could lead 
to a higher recording rate of symptom related events. As 
most patients already underwent repeated conventional-
UDS before additional ambulatory-UDS, the influence of 
this possible source of bias seems negligible.
Ambulatory urodynamic studies are more time-consum-
ing than conventional-UDS. It remains debatable when 
they can be of additional value in clinical diagnosis and 
treatment evaluation. This additional evaluation should be 
reserved for patients in which conventional pressure flow 
studies have failed to fully explain or reproduce the symp-
toms and where further knowledge is likely to aid in sub-
sequent management. Based on results from this study, we 
advise to perform ambulatory-UDS in patients with alleged 
diminished bladder contractility. The value of contractions 
during the filling phase with ambulatory-UDS in patients 
with OAB complaints, without DO on conventional-UDS, 
should be the subject of future research. Future studies 
should also define normal ranges for filling and voiding 
cystometry in ambulatory-UDS. This, in combination with 
the process of relating urodynamic results to treatment out-
comes in patients with lower urinary tract symptoms, will 
be useful in the clinical validation of ambulatory-UDS.
Conclusions
In patients with storage dysfunction, regardless of the pres-
ence of detrusor overactivity, additional ambulatory-UDS 
does not seem to contribute to a better prediction of suc-
cess with SNM. However, it could be of importance in other 
treatments. Ambulatory-UDS is more sensitive in detecting 
detrusor contractions in patients with voiding dysfunction. 
The success rate amongst the patients with hypocontractil-
ity or acontractility is higher based on conventional-UDS 
than on ambulatory-UDS. The most likely cause of this 
discrepancy is the overestimation of the amount of patients 
with impaired contractility when relying on conventional-
UDS. The diagnosis of a real acontractile bladder implicates 
an obvious high risk of failure of SNM. This information 
makes more accurate patient selection for SNM possible.
Therefore, ambulatory urodynamics could better guide 
treatment choice than conventional-UDS in these patients.
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